Rebound Growth of Infantile Hemangiomas After Propranolol Therapy

2016135 citationsJournal Article

Authors

Sonal D. Shah

Eulàlia Baselga · Hospital de Sant Pau

Catherine McCuaïg · Centre Hospitalier Universitaire Sainte-Justine

Elena Pope · University of Toronto

Julien Coulie · Cliniques Universitaires Saint-Luc

Laurence M. Boon · Cliniques Universitaires Saint-Luc

Maria C. Garzón · Columbia University

Abstract

Rebound growth occurred in 25% of patients, requiring modification of systemic therapy in 15%. Predictive factors for rebound growth included age of discontinuation, deep IH component, and female gender. Patients with these predictive factors may require a prolonged course of therapy.

Topics & Keywords

Vascular Malformations and Hemangiomas Central Venous Catheters and Hemodialysis Vascular Malformations Diagnosis and Treatment

Publication Details

Published in: PEDIATRICS

Volume 137, Issue 4

DOI: 10.1542/peds.2015-1754

Field-Weighted Citation Impact: 11.30

Command Palette

Rebound Growth of Infantile Hemangiomas After Propranolol Therapy

Authors

Abstract

Topics & Keywords

Publication Details